Decoy Therapeutics is trading at $1.03, up 12.83%, with broader biotech strength the likeliest available explanation—not a confirmed catalyst.
- XBI rose 2.18% during the regular session on October 27.
- No company-specific announcement explaining the October 27 move was found; Schwab listed no company headlines that day.
- Recent company updates predated October 27, so sector strength remains an unconfirmed explanation.